Evidence map›Paper›PMID 33086595›Full record

ArticleAntibiotics (Basel, Switzerland)2020

Aureolic Acid Group of Agents as Potential Antituberculosis Drugs.

Julia Bespyatykh, Dmitry Bespiatykh, Maja Malakhova, Ksenia Klimina, Andrey Bespyatykh, Anna Varizhuk, Anna Tevyashova, Tatiana Nikolenko, Galina Pozmogova, Elena Ilina and 1 more

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Julia BespyatykhFederal Research and Clinical Centre of Physical-Chemical Medicine, 119435 Moscow, Russia.ORCID 0000-0002-4408-503X
Dmitry BespiatykhFederal Research and Clinical Centre of Physical-Chemical Medicine, 119435 Moscow, Russia.ORCID 0000-0003-0867-5988
Maja MalakhovaFederal Research and Clinical Centre of Physical-Chemical Medicine, 119435 Moscow, Russia.
Ksenia KliminaFederal Research and Clinical Centre of Physical-Chemical Medicine, 119435 Moscow, Russia.
Andrey BespyatykhInstitute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.
Anna VarizhukFederal Research and Clinical Centre of Physical-Chemical Medicine, 119435 Moscow, Russia.
Anna TevyashovaGause Institute of New Antibiotics, 199021 Moscow, Russia.
Tatiana NikolenkoFederal Research and Clinical Centre of Physical-Chemical Medicine, 119435 Moscow, Russia.ORCID 0000-0002-9333-0193
Galina PozmogovaFederal Research and Clinical Centre of Physical-Chemical Medicine, 119435 Moscow, Russia.
Elena IlinaFederal Research and Clinical Centre of Physical-Chemical Medicine, 119435 Moscow, Russia.
Egor ShitikovFederal Research and Clinical Centre of Physical-Chemical Medicine, 119435 Moscow, Russia.
Federal Research and Clinical Center of Physical-Chemical Medicine named after Y.M. Lopukhin · RUGause Institute of New Antibiotics Russian Academy of Medical Sciences · RUKazan Federal University · RUMoscow Institute of Physics and Technology · RU

Funding

Russian Science Foundation 19-75-10109
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mycobacterium smegmatisMycobacterium tuberculosisOlivomycinTB treatmenttranscriptomic

Identifiers

PMID33086595
PMCPMC7650759
OpenAlexW3094498959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.